Amylyx Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
AMLX chart
What traders are saying about $AMLX
Latest postsAmylyx Pharmaceuticals, Inc. news
- Mizuho maintains Amylyx Pharmaceuticals at Outperform, raises price target to $39 from $38
TradingView ·
- Fund Update: New $7.2M $AMLX stock position opened by Universal- Beteiligungs- und Servicegesellschaft mbH
Quiver Quantitative ·
- Form 144 AMYLYX PHARMACEUTICALS For: 10 November By Investing.com
Investing.com India ·
- A director proposes selling 100,000 Amylyx (AMLX) shares valued at $2.95M.
Stock Titan ·
- An officer's proposed $1.18M Amylyx (AMLX) share sale covers 40,000 shares from option exercises.
Stock Titan ·
- A director proposes another share sale at Amylyx (AMLX) after selling $980K.
Stock Titan ·
- Amylyx Pharmaceuticals, Inc. (AMLX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Amylyx Pharmaceuticals (AMLX) Stock Still Trades At A Premium As Phase 3 Progress Advances
Simply Wall St ·
- Why Amylyx Pharmaceuticals Stock Is Up 6.8% And What's Next
Yahoo Finance ·
- Amylyx Pharmaceuticals (AMLX) Stock Looks Pricey After Positive Phase 3 Results
Yahoo Finance ·
- Amylyx Pharmaceuticals (AMLX) Posts Positive Phase 3 Data, Is The 30% Discount Justified?
Yahoo Finance ·
- Amylyx Pharmaceuticals Inc (AMLX) Q3 2026 Earnings Call Highlights: $768 Million Cash Position ...
Yahoo Finance ·
Amylyx Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $87.4M | $380.8M | $22.2M |
| Net income | -$144.7M | -$301.7M | $49.3M | -$198.4M |
| Diluted EPS | $-1.53 | $-4.43 | $0.70 | $-3.39 |
| Total assets (year end) | $332.6M | $193.6M | $517.5M | $391.5M |
| Cash and equivalents (year end) | $226.7M | $77.4M | $170.2M | $62.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Amylyx Pharmaceuticals, Inc.
- Ticker
- AMLX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1658551
Frequently asked questions
What exchange is Amylyx Pharmaceuticals, Inc. listed on?
Amylyx Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol AMLX.
What industry is Amylyx Pharmaceuticals, Inc. in?
Amylyx Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Amylyx Pharmaceuticals, Inc. headquartered?
Amylyx Pharmaceuticals, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Amylyx Pharmaceuticals, Inc.'s fiscal year end?
Amylyx Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Amylyx Pharmaceuticals, Inc. report?
Amylyx Pharmaceuticals, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.